Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological‐based pharmacokinetic modeling
Abstract Letermovir is approved for use in cytomegalovirus‐seropositive hematopoietic stem cell transplant recipients and is investigated in other transplant settings. Nonlinear pharmacokinetics (PKs) were observed in clinical studies after intravenous and oral dosing across a wide dose range, inclu...
Guardado en:
Autores principales: | Karsten Menzel (Autor), Yuhsin Kuo (Autor), Dapeng Chen (Autor), Georgy Hartmann (Autor), Ying‐Hong Wang (Autor), Carolyn R. Cho (Autor), Jacqueline B. McCrea (Autor), Kazuhiko Asari (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Wiley,
2023-06-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients
por: Marita Prohn, et al.
Publicado: (2021) -
Population pharmacokinetics of everolimus in patients with seizures associated with focal cortical dysplasia
por: Jinha Park, et al.
Publicado: (2023) -
Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer
por: Masaki Hirabatake, et al.
Publicado: (2022) -
Mechanistic Coupling of a Novel in silico Cotyledon Perfusion Model and a Physiologically Based Pharmacokinetic Model to Predict Fetal Acetaminophen Pharmacokinetics at Delivery
por: Paola Mian, et al.
Publicado: (2021) -
Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology-What's Next?-Joining Mechanistic and Epidemiological Approaches
por: Stephan Schmidt, et al.
Publicado: (2019)